XML 73 R39.htm IDEA: XBRL DOCUMENT v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)
3 Months Ended 12 Months Ended
Dec. 31, 2025
USD ($)
Sep. 30, 2025
USD ($)
shares
Dec. 31, 2024
USD ($)
Dec. 31, 2025
USD ($)
segment
shares
Dec. 31, 2024
USD ($)
Jul. 03, 2025
shares
Jul. 02, 2025
Concentration Risk [Line Items]              
Reverse stock split rounddown and cash in lieu payment       $ (1,000)      
Reverse stock split       1-for-3.33      
Net foreign exchange gains (losses)       $ 193,000 $ (93,000)    
Number of operating segments | segment       1      
Number of reportable segments | segment       1      
Contract assets $ 0   $ 0 $ 0 0    
Costs of revenue       6,381,000 5,379,000    
Advertising costs 0   0 0 0    
Research and development       18,310,000 15,120,000    
Impairment of long-lived assets $ 0   $ 0 0 0    
Additional Paid-in-Capital              
Concentration Risk [Line Items]              
Reverse stock split rounddown and cash in lieu payment   $ (1,000)   $ (1,000)      
Common Stock              
Concentration Risk [Line Items]              
Reverse stock split rounddown and cash in lieu payment (in shares) | shares   (108)   (108)      
IPO              
Concentration Risk [Line Items]              
Preferred stock, conversion date             Jul. 02, 2025
Warrants issued (in shares) | shares           168,898  
IPO | Underwriter              
Concentration Risk [Line Items]              
Preferred stock, conversion date             Jul. 02, 2025
Warrants issued (in shares) | shares           3,898  
Shipping and handling              
Concentration Risk [Line Items]              
Costs of revenue       $ 117,000 51,000    
Healthcare clinical trial activities              
Concentration Risk [Line Items]              
Research and development       $ 6,391,000 $ 7,647,000    
Revenue | Customer Concentration Risk | Customer One              
Concentration Risk [Line Items]              
Concentration risk, percentage       9.00% 10.00%    
Accounts Receivable | Customer Concentration Risk | Customer One              
Concentration Risk [Line Items]              
Concentration risk, percentage       22.00% 21.00%